For instance, mutations in TREM2, an immune cells receptor expressed on microglia, represent a risk factor for AD and other neurodegenerative diseases (Guerreiro et al., 2013; Jonsson et al., 2013). This evidence concerns the gene TREM2 and neurodegenerative disease.